Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43

Cancer Lett. 2007 Aug 18;253(2):249-57. doi: 10.1016/j.canlet.2007.01.021. Epub 2007 Mar 6.

Abstract

Bowman-Birk protease inhibitor (BBI) from soybean acts as a potential chemopreventive agent in several types of tumors. However, the mechanism is still unclear. The present study was undertaken to estimate a mechanism of BBI-dependent negative growth control of human osteosarcoma cell (U2OS cell). BBI had negative growth control of the cells via induction of connexin (Cx) 43, a tumor suppressor gene in U2OS cells. This negative growth control by BBI was abrogated under down-regulation of Cx43 induced by a Cx43 antisense nucleotide treatment. It was also found that the BBI-dependent induction of Cx43 was due to elevation of Cx43 mRNA and stabilization of Cx43 protein. Especially, BBI-dependent inhibition of chymotrypsin-like activity in proteasome contributed to stabilization of Cx43 protein. These results suggest that a major negative growth effect of BBI is based on the restoration of Cx43 expression in U2OS cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Bone Neoplasms / metabolism*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Connexin 43 / genetics
  • Connexin 43 / metabolism*
  • Humans
  • Osteosarcoma / metabolism*
  • Protease Inhibitors / pharmacology*
  • Trypsin Inhibitor, Bowman-Birk Soybean / pharmacology*
  • Up-Regulation

Substances

  • Antineoplastic Agents
  • Connexin 43
  • Protease Inhibitors
  • Trypsin Inhibitor, Bowman-Birk Soybean